Mycophenolate mofetil and systemic lupus erythematosus: an overview Academic Article uri icon

Overview

abstract

  • Mycophenolate mofetil (MMF) is an immunosuppressive agent used in transplantation, with evidence of superior protection against acute transplant rejection compared to azathioprine-containing regimens. Subsequently MMF has been used in a variety of autoimmune conditions. The major experience in systemic lupus erythematosus (SLE) has focused on proliferative lupus nephritis. Following its success in the treatment of lupus nephritis, MMF is now being used to control other SLE manifestations such as, lupus disease activity, haematological manifestations and resistant skin lupus. In this review, we discuss our own experience and the literature report about the use of MMF in SLE.

publication date

  • 2005

Research

keywords

  • Humans

    Immunosuppressive Agents/administration & dosage/pharmacology/*therapeutic use

    Lupus Erythematosus, Systemic/*drug therapy

    Mycophenolic Acid/administration & dosage/*analogs &

    derivatives/pharmacology/*therapeutic use

Identity

PubMed ID

  • 15803925

Additional Document Info

start page

  • s9

end page

  • 11

volume

  • 14 Suppl 1